Program Overview

 

Duke’s Hematology & Transfusion Medicine T32 training program seeks to develop future scientific leaders in the disciplines of hematology and transfusion medicine.  The Hematology T32 training grant is housed in the Division of Hematology, within the Department of Medicine of Duke University Medical Center. Additional programmatic support is provided by the Divisions of Hematological Malignancies and Cellular Therapy, Pediatric Hematology-Oncology and Pediatric Transplant and Cellular Therapies.

The  T32 training program accepts 3-4 postdoctoral fellows and two medical students per year on the basis of research proposals focused on one of four fields of study, including:

Track I: Transfusion Medicine and Hemoglobinopathies

Track II:  Hemostasis & Thrombosis

Track III: Hematopoiesis & Cellular Therapy

Track IV: Molecular Biology, Signaling & Genetics

Post-doctoral trainees pursue a research-intensive program in basic/translational or clinical investigation supplemented by educational and training program activities. Educational activities for postdoctoral trainees will include required coursework in statistics as related to their clinical or basic research interests, attendance at research conferences relevant to their training tracks and enrolling in graduate level courses to consolidate their scientific knowledge. Additional program activities are designed to bolster career development of individual trainees through regular career developmental seminars and monthly research-in-progress meetings .

Medical students will select from a list of preceptors with a benign hematology focus.   Preference will be given to URM candidates. Students are expected to pursue full-time (40 hours/week) research for a minimum of 8 weeks and a maximum of 12 weeks.   Students will be encouraged to participate in clinical shadowing activities once a month as related to their area research.

Upcoming Events

Loading...